top of page
Example company logo

Now Pharma

Home     About us     Services     News     Contact

Personal message for John Smith of Outreach Pharmaceuticals

Outreach Pharmat - Introduction - Audio onlyArtist Name
00:00 / 02:08

Audio-only track

Transcript

Hi, John.

 

I've worked in the rare disease space for years and have been following Outreach Pharma's successes, most notably the recent OP-101 Phase II study for porphyria.

Now Pharma is a specialist CRO in rare disease clinical trials, including porphyria studies. With the announcement of the planned OP-101 Phase III study, now may be a good time to connect. Our porphyria trial experience has shown that in addition to a well-designed protocol, dynamic supply management, a patient-centric approach, and strong analysis tools and methodologies, the CRO's level of relevant experience in this therapeutic area is critical.

Would you be open to having an introduction call? I could share insights that may be helpful for you. My calendar is here if you'd like to compare schedules. 


Kind regards,
 

Ray


Ray Collia
Director of Relationship
 Development

Now Phrama

Mobile +44 1234 123456

Email contact@nowpharma.com

Example company logo

Now Pharma

Resources for John Smith

Patient and Nurse

Porphyria Clinical Trial Case Study

Download

Laboratory

Overcoming Challenges in Rare Disease Studies

Read the blog

Happy Patient

Increasing Patient Retention

Read the blog

A Little About Now Pharma

Doctor's Appointment

Porphyria

Text will go here that relates to your prospect's core interests.

 

Doctor Using Digital Tablet

Research and Development

Text will go here that relates to your prospect's core interests.

bottom of page